Buzzing stocks
Pfizer India added over 5% to Rs 1,786 after the pharmaceutical major signed an agreement with AstraZeneca’s Swedish arm to acquire the latter’s drug, Neksium, for Rs 75 crore. Neksium was launched in India in 2006 and had developed strong equity with doctors, as a leading, high-quality product in the anti-peptic ulcerant space.
Among losers, Oil marketing companies (OMCs) such as IOC, BPCL, HPCL shed up to 2% after IOC announced an increase in the price of petrol and diesel with effect from the midnight of 31 May/1 June 2017.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)